Holdings of Bain Capital Life Sciences Investors, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 16 in 2 countries
- Top ten
- 90.6 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | HeartFlow Inc | 10,448,158 | 254.2M $ | |
| 2 | Olema Pharmaceuticals Inc | 7,473,238 | 111.4M $ | |
| 3 | SAVARA INC | 17,600,621 | 96.1M $ | |
| 4 | Solid Biosciences Inc | 9,808,819 | 70.6M $ | |
| 5 | X4 Pharmaceuticals Inc | 7,967,454 | 32.9M $ | |
| 6 | Dianthus Therapeutics Inc | 362,470 | 30.4M $ | |
| 7 | Annexon Inc | 5,212,674 | 28.9M $ | |
| 8 | Kyverna Therapeutics Inc | 3,110,000 | 26.8M $ | |
| 9 | CABALETTA BIO INC | 9,677,125 | 26M $ | |
| 10 | Centessa Pharmaceuticals PLC | 635,000 | 25.2M $ | |
| 11 | Rapid Micro Biosystems Inc | 8,434,560 | 19.1M $ | |
| 12 | C4 Therapeutics Inc | 7,171,910 | 18.9M $ | |
| 13 | Atea Pharmaceuticals Inc | 2,360,638 | 12.7M $ | |
| 14 | Disc Medicine Inc | 141,234 | 9M $ | |
| 15 | Upstream Bio Inc | 867,211 | 7.8M $ | |
| 16 | Xilio Therapeutics Inc | 664,021 | 5.6M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 96.7 %
- United Kingdom 3.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 15 | 750.6M $ | 96.75 % |
| 2 | United Kingdom | 1 | 25.2M $ | 3.25 % |
Cite this page
Titelia. "Holdings of Bain Capital Life Sciences Investors, LLC". https://titelia.com/en/funds/US13F1703031